AFAP-110 Antibodies

Santa Cruz Biotechnology delivers a wide array of AFAP-110 monoclonal antibodies for research focused on understanding AFAP-110's role in cellular processes. Multiple applications are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). AFAP-110, or Actin Filament Associated Protein 110, orchestrates actin cytoskeleton organization and cellular signaling pathways. AFAP-110 drives cell motility and adhesion while regulating various cellular functions, making it a key focus in cancer metastasis research. Scientists investigating AFAP-110 can gain valuable insights into cell behavior mechanisms and identify potential therapeutic targets. Research applications for AFAP-110 span across multiple areas of cell biology and disease studies. Advanced detection methods allow for precise visualization and quantification of AFAP-110 in diverse experimental setups. Comprehensive protocols and application guidelines ensure optimal results in different research settings. Santa Cruz Biotechnology monoclonal antibodies for AFAP-110 enable researchers worldwide to advance scientific understanding of cellular processes and disease mechanisms.